Jump to content
RemedySpot.com

Suspension of Rosiglitazone in India

Rate this topic


Guest guest

Recommended Posts

After the ban in Europe, restrictions in USA. India suspend the manufacture &

import of Rosiglitazone (antidiabetic)on Oct. 7. It was reported that the drug

produce commendable adverse cardiac events and bad lipid profiles.

Please check the Drug Controller General of India messages.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...